Published in Surg Clin North Am on April 26, 2012
Trans-oral approach for the management of a C2 neuroblastoma. Eur Spine J (2014) 1.40
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer (2012) 1.17
Pediatric genitourinary oncology. Front Pediatr (2013) 0.90
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells. PLoS One (2015) 0.84
Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford) (2013) 0.80
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment. Invest New Drugs (2012) 0.77
Stage IV Wilms Tumor Treated by Korean Medicine, Hyperthermia and Thymosin-α1: A Case Report. Case Rep Oncol (2016) 0.75
Sacrococcygeal Teratoma With Multiple Recurrences by Intradural Extension in the Neonate: A Common Neonatal Mass With an Unusual Course. Glob Pediatr Health (2014) 0.75
Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg (2013) 1.27
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res (2002) 1.10
Experience with alternate sources of venous inflow in the meso-Rex bypass operation: the coronary and splenic veins. J Pediatr Surg (2007) 1.05
H-type congenital tracheoesophageal fistula: University Of Iowa experience 1985 to 2005. Ann Otol Rhinol Laryngol (2007) 1.00
Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group. J Pediatr Hematol Oncol (2006) 0.95
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma. Cancer Immunol Immunother (2008) 0.90
Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. J Pediatr Surg (2006) 0.89
Use of autogenous saphenous vein as a conduit for mesenterico-left portal vein bypass. J Pediatr Surg (2007) 0.87
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma. J Pediatr Surg (2006) 0.87
Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance. Front Oncol (2012) 0.82
Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (2002) 0.82
Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis. Dev Dyn (2002) 0.82
Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors. J Pediatr Hematol Oncol (2005) 0.80
Surgical treatment of a gastric diverticulum in an adolescent. J Pediatr Surg (2006) 0.79
CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Adv Drug Deliv Rev (2009) 0.78
Robotic resection of mediastinal masses in children. J Laparoendosc Adv Surg Tech A (2008) 0.78
Increased incidence of perforated appendicitis in children with obesity. Clin Pediatr (Phila) (2012) 0.78
Immunostimulatory sutures that treat local disease recurrence following primary tumor resection. Biomed Mater (2011) 0.76
Management of congenital chest wall deformities. Semin Plast Surg (2011) 0.75
Immune stimulation for the treatment of papilloma. Ann Otol Rhinol Laryngol (2005) 0.75
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells. Cancer Immunol Immunother (2009) 0.75
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma. J Pediatr Surg (2005) 0.75